CS logo
small CS logo
Bay Area Retina Associates

Walnut Creek, California, United States
Ophthalmologist in Walnut Creek, California
365 Lennon Ln Suite 250, Walnut Creek, CA 94598

About Bay Area Retina Associates


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Jaeb Center for Health Research
11
Hoffmann-La Roche
9
Genentech, Inc.
3
Ribomic USA Inc
3
Apellis Pharmaceuticals, Inc.
2
Bay Area Retina Associates
2
Aerie Pharmaceuticals
1
AffaMed Therapeutics (US) Inc.
1
Allergan
1
Clearside Biomedical, Inc.
1
Graybug Vision
1
Total Rows: 18

Clinical Trials at Bay Area Retina Associates


During the past decade, Bay Area Retina Associates conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 16 clinical trials were completed, i.e. on average, 64% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 9 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22223355443333332222001122333333Started TrialsCompleted Trails201520162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration
2005-07-01
2007-12-01
Completed
120
A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)
2006-06-01
2008-02-01
Completed
121
Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema
2004-07-01
2008-10-01
Completed
840
Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration
2006-08-01
2009-12-01
Completed
60
Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema
2007-03-01
2014-02-01
Completed
691
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
2007-03-01
2010-07-01
Completed
333
Evaluation of Vitrectomy for Diabetic Macular Edema
2005-07-01
2009-02-01
Completed
87
A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet AMD
2008-01-01
2012-12-01
Completed
40

Rows per page:

1–42 of 42

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Bay Area Retina Associates" #1 sponsor was "Jaeb Center for Health Research" with 11 trials, followed by "Hoffmann-La Roche" with 9 trials sponsored, "Genentech, Inc." with 3 trials sponsored, "Ribomic USA Inc" with 3 trials sponsored and "Apellis Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Bay Area Retina Associates" #1 collaborator was "National Eye Institute (NEI)" with 11 trials as a collaborator, "Allergan" with 5 trials as a collaborator, "Genentech, Inc." with 5 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator and "Bay Area Retina Associates" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.
Created with Highcharts 11.1.0Top Leading SponsorsJaeb Center for HealthResearch: 11Jaeb Center for HealthResearch: 11Hoffmann-La Roche: 9Hoffmann-La Roche: 9Genentech, Inc.: 3Genentech, Inc.: 3Ribomic USA Inc: 3Ribomic USA Inc: 3Apellis Pharmaceuticals, Inc.: 2Apellis Pharmaceuticals, Inc.: 2Bay Area Retina Associates: 2Bay Area Retina Associates: 2Aerie Pharmaceuticals: 1Aerie Pharmaceuticals: 1AffaMed Therapeutics(US) Inc.: 1AffaMed Therapeutics(US) Inc.: 1Allergan: 1Allergan: 1Clearside Biomedical, Inc.: 1Clearside Biomedical, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsNational Eye Institute (NEI): 11National Eye Institute (NEI): 11Allergan: 5Allergan: 5Genentech, Inc.: 5Genentech, Inc.: 5Regeneron Pharmaceuticals: 2Regeneron Pharmaceuticals: 2Bay Area Retina Associates: 1Bay Area Retina Associates: 1National Institutes ofHealth (NIH): 1National Institutes ofHealth (NIH): 1Ophthalmic Consultantsof Boston: 1Ophthalmic Consultantsof Boston: 1QLT Inc.: 1QLT Inc.: 1

Clinical Trials Conditions at Bay Area Retina Associates


According to Clinical.Site data, the most researched conditions in "Bay Area Retina Associates" are "Diabetic Macular Edema" (15 trials), "Geographic Atrophy" (5 trials), "Age-Related Macular Degeneration" (3 trials), "Diabetic Retinopathy" (3 trials) and "Proliferative Diabetic Retinopathy" (3 trials). Many other conditions were trialed in "Bay Area Retina Associates" in a lesser frequency.

Clinical Trials Intervention Types at Bay Area Retina Associates


Most popular intervention types in "Bay Area Retina Associates" are "Drug" (37 trials), "Other" (9 trials), "Procedure" (7 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ranibizumab" (9 trials), "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "Faricimab" (4 trials) and "Sham injection" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Bay Area Retina Associates


The vast majority of trials in "Bay Area Retina Associates" are 42 trials for "All" genders.

Clinical Trials Status at Bay Area Retina Associates


Currently, there are NaN active trials in "Bay Area Retina Associates". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Bay Area Retina Associates, undefined suspended trials, and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Bay Area Retina Associates, 4 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 19Phase 2: 19Phase 3: 17Phase 3: 17Phase 1: 4Phase 1: 4Not Applicable: 1Not Applicable: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 28Completed: 28Recruiting: 6Recruiting: 6Terminated: 5Terminated: 5Active, not recruiting: 3Active, not recruiting: 3